DOBUTAMINE HYDROCHLORIDE

DOBUTAMINE HYDROCHLORIDE was reported 1297 times

DOBUTAMINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 WALL MOTION SCORE INDEX ABNORMAL 41 0.3727
1 SLEEP DISORDER THERAPY 73 0.3687
2 ANTACID THERAPY 47 0.3615
3 APPENDICOLITH 109 0.2817
4 ANALGESIC THERAPY 75 0.2336
5 DRUG THERAPY 75 0.2212
6 MALIGNANT MELANOMA STAGE 0 38 0.1818
7 ANTICOAGULANT THERAPY 47 0.1655
8 CONGENITAL HIATUS HERNIA 36 0.1579
9 CATHETER SITE ECZEMA 1 0.1429
10 DYSPROSODY 2 0.1053
11 ALLERGIC MYOCARDITIS 7 0.1029
12 BACTEROIDES INFECTION 24 0.0920
13 SPONDYLOEPIPHYSEAL DYSPLASIA 1 0.0833
14 CARDIAC STRESS TEST ABNORMAL 60 0.0723
15 SYSTEMIC VIRAL INFECTION 1 0.0714
16 COLONIC ANGIOECTASIA 1 0.0625
17 BEZOLD-JARISCH REFLEX 2 0.0526
18 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 39 0.0421
19 ACQUIRED LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 2 0.0408
20 HYPERPHOSPHATAEMIA 84 0.0390
21 PULSE WAVEFORM ABNORMAL 1 0.0357
22 BLOOD PHOSPHORUS INCREASED 93 0.0340
23 CARDIOTHORACIC RATIO INCREASED 2 0.0317
24 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 11 0.0316
25 RASH NEONATAL 1 0.0303
26 CATHETER SITE DERMATITIS 1 0.0278
27 CANDIDA OSTEOMYELITIS 1 0.0270
28 VENIPUNCTURE 1 0.0233
29 INTRA-AORTIC BALLOON PLACEMENT 1 0.0213
30 INTENSIVE CARE UNIT DELIRIUM 1 0.0208
31 ENDOCARDIAL FIBROSIS 1 0.0189
32 VASCULAR ACCESS MALFUNCTION 1 0.0185
33 PULMONARY CAPILLARY HAEMANGIOMATOSIS 1 0.0182
34 BLOOD FIBRINOGEN ABNORMAL 1 0.0175
35 POSTHAEMORRHAGIC HYDROCEPHALUS 1 0.0172
36 HYPERSENSITIVITY MYOCARDITIS 2 0.0165
37 LUNG ASSIST DEVICE THERAPY 1 0.0161
38 AUTOIMMUNE HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0159
39 TOTAL LUNG CAPACITY DECREASED 25 0.0156
40 PAPILLARY MUSCLE RUPTURE 1 0.0156
41 EOSINOPHILIC MYOCARDITIS 11 0.0151
42 LEFT VENTRICULAR OUTFLOW TRACT GRADIENT INCREASED 1 0.0147
43 IRON DEFICIENCY 64 0.0142
44 WRONG PRODUCT STORED 4 0.0141
45 BLOOD URIC ACID INCREASED 80 0.0138
46 RAOULTELLA ORNITHINOLYTICA INFECTION 1 0.0130
47 PLEURITIC PAIN 35 0.0127
48 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 64 0.0126
49 SKIN LESION EXCISION 1 0.0125
50 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 1 0.0125
51 MYASTHENIA GRAVIS 100 0.0124
52 RIGHT ATRIAL PRESSURE INCREASED 1 0.0123
53 CYCLOTHYMIC DISORDER 2 0.0122
54 APPENDICITIS 111 0.0119
55 HYPOPHOSPHATAEMIA 86 0.0116
56 AORTIC STENOSIS 40 0.0115
57 NEONATAL CARDIAC FAILURE 1 0.0111
58 RESPIRATORY SYMPTOM 31 0.0109
59 PULMONARY HAEMORRHAGE NEONATAL 1 0.0109
60 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY 1 0.0109
61 PLATELET TOXICITY 1 0.0109
62 VENTRICULAR FIBRILLATION 119 0.0107
63 ANAPHYLACTOID SYNDROME OF PREGNANCY 1 0.0104
64 TANGENTIALITY 2 0.0104
65 ANAL RASH 1 0.0104
66 CHORDAE TENDINAE RUPTURE 1 0.0102
67 LUNG OPACITY 26 0.0099
68 CARDIAC VALVE RUPTURE 1 0.0098
69 CARDIAC INDEX DECREASED 1 0.0097
70 INFERIOR VENA CAVA DILATATION 2 0.0095
71 ATELECTASIS NEONATAL 1 0.0093
72 GAMMA-GLUTAMYLTRANSFERASE 1 0.0092
73 PENILE NECROSIS 1 0.0090
74 CARDIOGENIC SHOCK 129 0.0090
75 CHEST WALL TUMOUR 1 0.0083
76 CENTRAL VENOUS PRESSURE INCREASED 1 0.0082
77 BURKHOLDERIA TEST POSITIVE 1 0.0081
78 HEPATO-LENTICULAR DEGENERATION 1 0.0079
79 STRESS CARDIOMYOPATHY 46 0.0079
80 TROPONIN INCREASED 56 0.0074
81 BENIGN PROSTATIC HYPERPLASIA 38 0.0074
82 LYMPHOCYTIC HYPOPHYSITIS 2 0.0072
83 REPERFUSION INJURY 1 0.0072
84 PERICARDIAL FIBROSIS 1 0.0072
85 POSTOPERATIVE RENAL FAILURE 1 0.0069
86 IDIOPATHIC PNEUMONIA SYNDROME 2 0.0067
87 RESTRICTIVE CARDIOMYOPATHY 2 0.0066
88 BREATH SOUNDS ABNORMAL 32 0.0065
89 ENTEROBACTER PNEUMONIA 1 0.0064
90 LOW CARDIAC OUTPUT SYNDROME 2 0.0060
91 GASTROINTESTINAL MUCORMYCOSIS 1 0.0060
92 CARDIAC OUTPUT INCREASED 1 0.0058
93 POST PROCEDURAL STROKE 1 0.0054
94 BLOOD CALCIUM INCREASED 47 0.0054
95 MULTIPLE ORGAN DYSFUNCTION SYNDROME 148 0.0052
96 BACTERIAL INFECTION 91 0.0049
97 HYPERLIPIDAEMIA 58 0.0048
98 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 81 0.0047
99 TRANSFERRIN SATURATION DECREASED 2 0.0047
100 ATRIOVENTRICULAR DISSOCIATION 1 0.0047
101 HEARING AID USER 2 0.0047
102 LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED 1 0.0046
103 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 3 0.0045
104 IRON BINDING CAPACITY TOTAL DECREASED 1 0.0045
105 CARCINOID CRISIS 1 0.0044
106 INFUSION SITE PHLEBITIS 1 0.0044
107 PROPOFOL INFUSION SYNDROME 3 0.0043
108 CLOSTRIDIAL SEPSIS 1 0.0041
109 POSTICTAL PARALYSIS 1 0.0041
110 CARDIAC VALVE REPLACEMENT COMPLICATION 1 0.0041
111 ASCITES 120 0.0041
112 HYPERDYNAMIC LEFT VENTRICLE 1 0.0041
113 CHEYNE-STOKES RESPIRATION 1 0.0040
114 RAPID CORRECTION OF HYPONATRAEMIA 1 0.0040
115 ULCER 63 0.0040
116 METASTASES TO SOFT TISSUE 1 0.0039
117 NEURALGIA 93 0.0038
118 COOMBS TEST POSITIVE 1 0.0037
119 ASPIRATION 40 0.0036
120 NEWBORN PERSISTENT PULMONARY HYPERTENSION 1 0.0036
121 FEAR OF DEATH 8 0.0036
122 GOUT 63 0.0035
123 HYPERCHOLESTEROLAEMIA 33 0.0034
124 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
125 BLOOD TEST ABNORMAL 47 0.0033
126 SUSPECTED OFF LABEL USE 15 0.0033
127 HEART TRANSPLANT 3 0.0033
128 PRODUCT PACKAGING CONFUSION 8 0.0033
129 END STAGE RENAL DISEASE 60 0.0033
130 ARTERIOSPASM CORONARY 13 0.0032
131 PARAPROTEINAEMIA 1 0.0032
132 HEPATIC ISCHAEMIA 1 0.0032
133 DEVICE PROGRAMMING ERROR 1 0.0032
134 ABDOMINAL COMPARTMENT SYNDROME 2 0.0031
135 RIGHT VENTRICULAR ENLARGEMENT 1 0.0031
136 FULL BLOOD COUNT ABNORMAL 33 0.0031
137 MICTURITION URGENCY 35 0.0031
138 METASTATIC GASTRIC CANCER 1 0.0029
139 FUNGAL TEST POSITIVE 1 0.0028
140 CATHETER REMOVAL 1 0.0028
141 NEONATAL HYPOTENSION 1 0.0027
142 SHOCK SYMPTOM 1 0.0027
143 FEAR 72 0.0027
144 VIRAL MYOCARDITIS 1 0.0027
145 THROMBOTIC CEREBRAL INFARCTION 1 0.0027
146 HYPERNATRAEMIA 13 0.0026
147 ADMINISTRATION SITE REACTION 1 0.0026
148 RIGHT VENTRICULAR FAILURE 18 0.0026
149 TRI-IODOTHYRONINE INCREASED 1 0.0025
150 VITAMIN K DEFICIENCY 1 0.0025
151 MULTI-ORGAN FAILURE 43 0.0025
152 ENTEROCOCCAL SEPSIS 2 0.0025
153 CRANIOTOMY 1 0.0024
154 HYPONATRAEMIA 132 0.0023
155 CORONARY ARTERY DISSECTION 2 0.0023
156 CARDIAC OUTPUT DECREASED 2 0.0023
157 CEREBRAL MICROHAEMORRHAGE 1 0.0022
158 PULMONARY EOSINOPHILIA 1 0.0022
159 ANEURYSM RUPTURED 2 0.0022
160 PRIMARY BILIARY CHOLANGITIS 1 0.0021
161 PULMONARY VASCULAR DISORDER 1 0.0021
162 ECZEMA ASTEATOTIC 1 0.0021
163 INTUSSUSCEPTION 2 0.0021
164 ANHEDONIA 55 0.0021
165 ANAEMIA NEONATAL 1 0.0021
166 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
167 CONTINUOUS HAEMODIAFILTRATION 2 0.0020
168 ENDOCARDITIS STAPHYLOCOCCAL 1 0.0020
169 GENITAL ERYTHEMA 1 0.0020
170 MYOGLOBINURIA 1 0.0019
171 HYPEREOSINOPHILIC SYNDROME 1 0.0018
172 PRODUCT SELECTION ERROR 2 0.0018
173 RENAL INJURY 53 0.0018
174 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 93 0.0018
175 ENCEPHALOMALACIA 1 0.0018
176 ANTI FACTOR VIII ANTIBODY POSITIVE 1 0.0018
177 ARTERIAL HAEMORRHAGE 2 0.0017
178 CEREBRAL VENTRICLE DILATATION 2 0.0017
179 JOINT INJURY 37 0.0017
180 RIGHT VENTRICULAR DILATATION 1 0.0017
181 MEDIASTINITIS 1 0.0017
182 RALES 10 0.0017
183 GRAFT COMPLICATION 1 0.0017
184 BLOOD CHOLESTEROL INCREASED 78 0.0017
185 TRANSAMINASES INCREASED 37 0.0017
186 PERSISTENT FOETAL CIRCULATION 1 0.0016
187 PARACENTESIS 1 0.0016
188 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
189 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
190 BACILLUS INFECTION 1 0.0016
191 DRY GANGRENE 1 0.0016
192 THYROXINE FREE INCREASED 1 0.0016
193 VENTRICULAR HYPOKINESIA 5 0.0016
194 SLOW RESPONSE TO STIMULI 2 0.0015
195 VENTRICULAR DYSFUNCTION 4 0.0015
196 CHONDROCALCINOSIS 1 0.0015
197 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 5 0.0015
198 ILEAL PERFORATION 1 0.0015
199 CARDIAC FAILURE ACUTE 10 0.0015
200 MYOCARDIAL ISCHAEMIA 17 0.0015
201 BRONCHIECTASIS 10 0.0015
202 HYPOPLASTIC LEFT HEART SYNDROME 1 0.0015
203 FOETAL EXPOSURE DURING DELIVERY 1 0.0015
204 STASIS DERMATITIS 1 0.0015
205 ISCHAEMIC HEPATITIS 2 0.0015
206 RHONCHI 2 0.0014
207 PULMONARY VENO-OCCLUSIVE DISEASE 1 0.0014
208 HEPARIN-INDUCED THROMBOCYTOPENIA 7 0.0014
209 DEVICE ELECTRICAL FINDING 1 0.0014
210 NEONATAL ASPHYXIA 1 0.0014
211 CARDIAC FAILURE CHRONIC 6 0.0014
212 CATHETER SITE ERYTHEMA 3 0.0014
213 SEPSIS 155 0.0014
214 CHYLOTHORAX 1 0.0014
215 TRANSIENT GLOBAL AMNESIA 1 0.0014
216 SYSTEMIC SCLERODERMA 1 0.0014
217 PRODUCT LABEL CONFUSION 8 0.0014
218 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
219 PSEUDOMEMBRANOUS COLITIS 3 0.0013
220 ARTERIAL INJURY 1 0.0013
221 BRAIN HERNIATION 4 0.0013
222 CHOLANGITIS ACUTE 1 0.0013
223 HAEMOLYTIC URAEMIC SYNDROME 3 0.0013
224 CORONARY ARTERY DISEASE 39 0.0013
225 LABORATORY TEST INTERFERENCE 1 0.0013
226 EYELID FUNCTION DISORDER 1 0.0013
227 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
228 GOUTY ARTHRITIS 1 0.0013
229 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
230 BRONCHOPULMONARY DYSPLASIA 1 0.0012
231 SIMPLE PARTIAL SEIZURES 1 0.0012
232 DIABETES MELLITUS 94 0.0012
233 SPUTUM CULTURE POSITIVE 1 0.0012
234 CARDIOVASCULAR DISORDER 31 0.0012
235 VASOPLEGIA SYNDROME 2 0.0012
236 PERITONEAL DIALYSIS 1 0.0012
237 GENERAL PHYSICAL HEALTH DETERIORATION 140 0.0012
238 BRADYCARDIA FOETAL 1 0.0012
239 CATHETER SITE HAEMORRHAGE 3 0.0012
240 CULTURE POSITIVE 1 0.0012
241 INJURY 83 0.0012
242 SUDDEN CARDIAC DEATH 4 0.0012
243 NODAL ARRHYTHMIA 1 0.0012
244 THROMBOSIS 93 0.0012
245 GENITAL BURNING SENSATION 1 0.0012
246 SLEEP DISORDER 80 0.0011
247 DRUG MONITORING PROCEDURE NOT PERFORMED 2 0.0011
248 LOWER RESPIRATORY TRACT INFECTION 50 0.0011
249 TRANSIENT ISCHAEMIC ATTACK 37 0.0011
250 VASOSPASM 1 0.0011
251 HAEMOCHROMATOSIS 1 0.0011
252 ABDOMINAL DISTENSION 113 0.0011
253 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
254 DRY MOUTH 87 0.0011
255 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0011
256 CATHETER SITE SWELLING 1 0.0011
257 HEPATIC CONGESTION 1 0.0011
258 SPUTUM DISCOLOURED 10 0.0011
259 ELECTROCARDIOGRAM CHANGE 1 0.0011
260 INTENTIONAL PRODUCT MISUSE 91 0.0010
261 PCO2 DECREASED 1 0.0010
262 RED BLOOD CELLS URINE POSITIVE 1 0.0010
263 UNEVALUABLE EVENT 77 0.0010
264 PRINZMETAL ANGINA 1 0.0010
265 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
266 SWELLING 93 0.0010
267 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
268 PULMONARY EMBOLISM 94 0.0010
269 CATHETER RELATED INFECTION 1 0.0010
270 VASCULAR STENT THROMBOSIS 2 0.0010
271 PLEURAL FIBROSIS 1 0.0010
272 PERIPHERAL ISCHAEMIA 4 0.0010
273 LIVER FUNCTION TEST INCREASED 21 0.0010
274 AKINESIA 2 0.0010
275 DRUG INTOLERANCE 93 0.0010
276 INSULIN RESISTANCE 2 0.0010
277 LIVEDO RETICULARIS 2 0.0010
278 HYPOPERFUSION 1 0.0010
279 LIVER DISORDER 42 0.0009
280 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 1 0.0009
281 ORTHOPNOEA 3 0.0009
282 IRON OVERLOAD 1 0.0009
283 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
284 DEAFNESS NEUROSENSORY 3 0.0009
285 CARDIAC AMYLOIDOSIS 1 0.0009
286 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
287 HAEMOPTYSIS 25 0.0009
288 PULMONARY HAEMORRHAGE 7 0.0009
289 LARGE INTESTINAL HAEMORRHAGE 2 0.0009
290 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
291 ATRIAL FIBRILLATION 86 0.0009
292 THYROTOXIC CRISIS 1 0.0009
293 PO2 DECREASED 1 0.0009
294 IRON DEFICIENCY ANAEMIA 8 0.0009
295 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
296 BLOOD CREATININE INCREASED 56 0.0009
297 CARDIAC TAMPONADE 4 0.0008
298 PNEUMONIA INFLUENZAL 1 0.0008
299 VENTRICULAR ARRHYTHMIA 3 0.0008
300 PHARYNGEAL HAEMORRHAGE 1 0.0008
301 OLIGURIA 5 0.0008
302 UPPER RESPIRATORY TRACT INFECTION 37 0.0008
303 BRADYCARDIA NEONATAL 1 0.0008
304 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
305 OESOPHAGEAL ULCER 3 0.0008
306 PLATELET TRANSFUSION 1 0.0008
307 PULMONARY HYPERTENSION 16 0.0008
308 URINE OUTPUT INCREASED 2 0.0008
309 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
310 ORGAN FAILURE 3 0.0007
311 BLOOD SODIUM INCREASED 2 0.0007
312 PULMONARY MASS 11 0.0007
313 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
314 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
315 CARDIOVERSION 1 0.0007
316 ASPARTATE AMINOTRANSFERASE INCREASED 38 0.0007
317 PROTHROMBIN TIME SHORTENED 1 0.0007
318 BRASH SYNDROME 1 0.0007
319 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
320 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
321 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
322 MITRAL VALVE INCOMPETENCE 8 0.0007
323 GENITAL RASH 1 0.0007
324 TRACHEOSTOMY 1 0.0007
325 SPEECH DISORDER DEVELOPMENTAL 2 0.0007
326 VASCULAR INJURY 1 0.0007
327 GASTROINTESTINAL NECROSIS 2 0.0007
328 PULMONARY VALVE INCOMPETENCE 1 0.0007
329 NODAL RHYTHM 1 0.0007
330 RENAL IMPAIRMENT 57 0.0007
331 STEVENS-JOHNSON SYNDROME 15 0.0007
332 HEPATITIS FULMINANT 2 0.0007
333 ILEUS PARALYTIC 3 0.0007
334 RENAL FAILURE 89 0.0007
335 VENTRICULAR TACHYCARDIA 11 0.0007
336 MYOCLONIC EPILEPSY 1 0.0007
337 MARASMUS 1 0.0007
338 NEPHROGENIC ANAEMIA 3 0.0006
339 TORSADE DE POINTES 5 0.0006
340 EOSINOPHILIC PNEUMONIA 2 0.0006
341 NEONATAL DISORDER 1 0.0006
342 HEPATIC CYTOLYSIS 8 0.0006
343 HYPOXIA 22 0.0006
344 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
345 LUNG DISORDER 30 0.0006
346 MYOCARDITIS 7 0.0006
347 THROMBOSIS IN DEVICE 2 0.0006
348 CARDIOMYOPATHY 9 0.0006
349 BRADYARRHYTHMIA 1 0.0006
350 ANAEMIA 116 0.0006
351 SEBORRHOEIC DERMATITIS 1 0.0006
352 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
353 TROPONIN I INCREASED 1 0.0006
354 CARDIAC FAILURE 48 0.0006
355 BLOOD UREA INCREASED 10 0.0006
356 MUSCULOSKELETAL STIFFNESS 52 0.0006
357 CEREBELLAR INFARCTION 1 0.0006
358 SEIZURE LIKE PHENOMENA 1 0.0006
359 FIXED ERUPTION 1 0.0006
360 THYROIDECTOMY 1 0.0006
361 HYPOPITUITARISM 1 0.0006
362 VASCULAR PSEUDOANEURYSM 1 0.0006
363 SPLENIC INFARCTION 1 0.0006
364 EXTREMITY NECROSIS 1 0.0006
365 PSEUDOMONAL SEPSIS 1 0.0006
366 NEONATAL RESPIRATORY DISTRESS SYNDROME 2 0.0006
367 AORTIC VALVE STENOSIS 1 0.0006
368 PLEURAL EFFUSION 34 0.0006
369 TETANY 1 0.0005
370 CATHETER PLACEMENT 1 0.0005
371 GRANULOCYTE COUNT DECREASED 1 0.0005
372 EMOTIONAL DISTRESS 65 0.0005
373 SOMNOLENCE 108 0.0005
374 STENOSIS 1 0.0005
375 CATHETER SITE INFECTION 2 0.0005
376 MECHANICAL VENTILATION 1 0.0005
377 HAEMODYNAMIC INSTABILITY 4 0.0005
378 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
379 SHOCK 12 0.0005
380 PULMONARY FIBROSIS 10 0.0005
381 RHEUMATIC DISORDER 1 0.0005
382 VENOUS THROMBOSIS 2 0.0005
383 MULTI-ORGAN DISORDER 1 0.0005
384 CANDIDIASIS 2 0.0005
385 MUCOSAL DRYNESS 1 0.0005
386 CONSTIPATION 107 0.0005
387 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
388 SKIN INDURATION 1 0.0005
389 MICROCYTIC ANAEMIA 1 0.0005
390 CONDITION AGGRAVATED 145 0.0005
391 ATRIAL TACHYCARDIA 1 0.0005
392 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
393 ABDOMINAL PAIN 109 0.0005
394 NOSOCOMIAL INFECTION 1 0.0005
395 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
396 HEPATOCELLULAR DAMAGE 1 0.0004
397 CHRONIC GASTRITIS 1 0.0004
398 GASTRIC POLYPS 1 0.0004
399 DISTRIBUTIVE SHOCK 1 0.0004
400 METASTASES TO MENINGES 1 0.0004
401 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
402 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
403 PNEUMONIA BACTERIAL 4 0.0004
404 BILIRUBIN CONJUGATED INCREASED 1 0.0004
405 OEDEMA PERIPHERAL 52 0.0004
406 PRURITUS GENITAL 1 0.0004
407 BACTERAEMIA 5 0.0004
408 PULSE ABSENT 2 0.0004
409 MYOCLONUS 5 0.0004
410 OXYGEN CONSUMPTION INCREASED 1 0.0004
411 HYPOVOLAEMIC SHOCK 2 0.0004
412 LONG QT SYNDROME 1 0.0004
413 CIRCULATORY COLLAPSE 7 0.0004
414 GENERALISED OEDEMA 5 0.0004
415 ORGANISING PNEUMONIA 2 0.0004
416 HEART INJURY 1 0.0004
417 SYSTEMIC CANDIDA 1 0.0004
418 VASODILATATION 1 0.0004
419 OSTEITIS 1 0.0004
420 DERMATOMYOSITIS 1 0.0004
421 ACIDOSIS 3 0.0004
422 CANCER PAIN 1 0.0004
423 DEVICE RELATED INFECTION 6 0.0004
424 PERICARDIAL EFFUSION 9 0.0004
425 CEREBRAL ISCHAEMIA 2 0.0004
426 PHYSICAL DECONDITIONING 1 0.0004
427 VENTRICULAR EXTRASYSTOLES 4 0.0004
428 ASTHMA 43 0.0004
429 BLOOD LACTIC ACID INCREASED 2 0.0004
430 GASTROINTESTINAL DISORDER 34 0.0004
431 TRICUSPID VALVE INCOMPETENCE 3 0.0004
432 ATRIAL FLUTTER 3 0.0004
433 AREFLEXIA 1 0.0004
434 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
435 GASTRIC PERFORATION 1 0.0004
436 GASTRIC ULCER HAEMORRHAGE 2 0.0004
437 ANGIOPATHY 2 0.0004
438 ACUTE PULMONARY OEDEMA 2 0.0004
439 HYPERTENSION 75 0.0004
440 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
441 OXYGEN SATURATION ABNORMAL 1 0.0004
442 PSEUDOMONAS INFECTION 3 0.0003
443 ANURIA 3 0.0003
444 HYPERTHYROIDISM 5 0.0003
445 DYSPNOEA AT REST 1 0.0003
446 HYPERVENTILATION 2 0.0003
447 BILIARY COLIC 1 0.0003
448 HISTIOCYTOSIS HAEMATOPHAGIC 1 0.0003
449 INFUSION SITE REACTION 1 0.0003
450 ATYPICAL PNEUMONIA 1 0.0003
451 METABOLIC ENCEPHALOPATHY 1 0.0003
452 THYROIDITIS 1 0.0003
453 HYPERCAPNIA 1 0.0003
454 HIV INFECTION 1 0.0003
455 PRODUCT USE IN UNAPPROVED INDICATION 82 0.0003
456 RENAL FAILURE ACUTE 14 0.0003
457 ADRENAL INSUFFICIENCY 4 0.0003
458 CHEST X-RAY ABNORMAL 1 0.0003
459 CARDIOMEGALY 4 0.0003
460 INFUSION SITE PRURITUS 1 0.0003
461 DEATH 271 0.0003
462 PULMONARY CONGESTION 4 0.0003
463 DRUG LEVEL INCREASED 5 0.0003
464 SALIVARY HYPERSECRETION 3 0.0003
465 PROSTATE CANCER METASTATIC 1 0.0003
466 SEPTIC SHOCK 13 0.0003
467 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
468 CEREBRAL HAEMATOMA 1 0.0003
469 WOUND DEHISCENCE 1 0.0003
470 ULCER HAEMORRHAGE 2 0.0003
471 HEPATIC FIBROSIS 1 0.0003
472 LEFT VENTRICULAR FAILURE 1 0.0003
473 DROOLING 2 0.0003
474 ANXIETY 82 0.0003
475 EXTRASYSTOLES 2 0.0003
476 TRANSFUSION 3 0.0003
477 BLOOD PRESSURE DECREASED 19 0.0003
478 THROMBOPHLEBITIS 1 0.0003
479 JAUNDICE CHOLESTATIC 1 0.0003
480 PULMONARY TOXICITY 2 0.0003
481 LUNG TRANSPLANT 1 0.0003
482 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
483 SINUS TACHYCARDIA 4 0.0003
484 HAEMORRHAGIC DIATHESIS 1 0.0003
485 LACTIC ACIDOSIS 9 0.0003
486 LIVER TRANSPLANT 1 0.0003
487 FAECES SOFT 2 0.0003
488 MOUTH HAEMORRHAGE 2 0.0003
489 AMYLASE INCREASED 1 0.0003
490 PSYCHIATRIC SYMPTOM 2 0.0003
491 CARDIAC DYSFUNCTION 1 0.0003
492 HEPATIC NECROSIS 1 0.0003
493 HYPOCALCAEMIA 5 0.0003
494 HYPERTHERMIA 2 0.0003
495 PROCEDURAL COMPLICATION 2 0.0003
496 CHOLESTASIS 5 0.0003
497 RENAL FAILURE CHRONIC 2 0.0003
498 REHABILITATION THERAPY 1 0.0003
499 PANIC DISORDER 1 0.0003
500 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
501 CAESAREAN SECTION 3 0.0003
502 LUNG INFECTION 4 0.0003
503 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
504 EJECTION FRACTION DECREASED 4 0.0003
505 EPIGASTRIC DISCOMFORT 1 0.0003
506 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
507 CEREBRAL ATROPHY 1 0.0003
508 AZOTAEMIA 1 0.0003
509 VOMITING 117 0.0002
510 SHOCK HAEMORRHAGIC 2 0.0002
511 HYPERURICAEMIA 1 0.0002
512 EXTRAVASATION 1 0.0002
513 LEG AMPUTATION 1 0.0002
514 AORTIC DISSECTION 1 0.0002
515 ILEUS 3 0.0002
516 GASTROINTESTINAL PERFORATION 1 0.0002
517 CONGESTIVE CARDIOMYOPATHY 1 0.0002
518 HAEMODIALYSIS 2 0.0002
519 BUNDLE BRANCH BLOCK LEFT 1 0.0002
520 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
521 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
522 MYOPATHY 2 0.0002
523 CARDIAC ARREST 19 0.0002
524 TUMOUR LYSIS SYNDROME 2 0.0002
525 PURPURA 2 0.0002
526 BLOOD CREATINE INCREASED 1 0.0002
527 DRUG ERUPTION 4 0.0002
528 WRONG DRUG ADMINISTERED 2 0.0002
529 CARDIAC FAILURE CONGESTIVE 18 0.0002
530 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
531 LEUKOCYTOSIS 4 0.0002
532 VASCULAR DEVICE INFECTION 1 0.0002
533 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
534 HAEMOGLOBIN INCREASED 1 0.0002
535 ISCHAEMIA 1 0.0002
536 TREMOR 36 0.0002
537 NEPHROPATHY 2 0.0002
538 NERVOUSNESS 11 0.0002
539 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
540 ATELECTASIS 2 0.0002
541 SINUS BRADYCARDIA 2 0.0002
542 THROMBOTIC MICROANGIOPATHY 2 0.0002
543 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
544 STAPHYLOCOCCAL SEPSIS 1 0.0002
545 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
546 PULMONARY OEDEMA 9 0.0002
547 PROTEIN URINE PRESENT 1 0.0002
548 DERMATITIS EXFOLIATIVE 1 0.0002
549 TOXIC SKIN ERUPTION 2 0.0002
550 KLEBSIELLA INFECTION 1 0.0002
551 PATHOLOGICAL FRACTURE 1 0.0002
552 SUBARACHNOID HAEMORRHAGE 2 0.0002
553 AMMONIA INCREASED 1 0.0002
554 PETIT MAL EPILEPSY 1 0.0002
555 PAIN 120 0.0002
556 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
557 ENDOCARDITIS 1 0.0002
558 PRODUCT COLOUR ISSUE 1 0.0002
559 THYROID DISORDER 3 0.0002
560 STOMACH DISCOMFORT 1 0.0002
561 RESPIRATORY FAILURE 14 0.0002
562 PARTIAL SEIZURES 1 0.0002
563 PNEUMOTHORAX 3 0.0002
564 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
565 PREMATURE DELIVERY 3 0.0002
566 PLATELET COUNT DECREASED 20 0.0002
567 COMPRESSION FRACTURE 1 0.0002
568 WHEEZING 11 0.0002
569 OFF LABEL USE 162 0.0002
570 DYSPNOEA 104 0.0002
571 HYDROCEPHALUS 1 0.0002
572 INTESTINAL ISCHAEMIA 1 0.0002
573 COAGULOPATHY 3 0.0002
574 NECROSIS 1 0.0002
575 CANDIDA INFECTION 3 0.0002
576 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
577 PERONEAL NERVE PALSY 1 0.0002
578 NEUTROPHILIA 1 0.0002
579 DERMATITIS CONTACT 2 0.0002
580 DELIRIUM 6 0.0002
581 VASCULITIS 2 0.0002
582 EOSINOPHILIA 3 0.0002
583 HYPERKALAEMIA 6 0.0002
584 HYPOVOLAEMIA 1 0.0002
585 HEART RATE DECREASED 6 0.0002
586 BLOOD IRON DECREASED 2 0.0002
587 CEREBRAL HAEMORRHAGE 6 0.0002
588 ENDOPHTHALMITIS 1 0.0002
589 HEPATITIS B 1 0.0002
590 HEPATIC FAILURE 5 0.0002
591 HEPATITIS C 2 0.0002
592 MENTAL IMPAIRMENT 4 0.0002
593 SCHIZOPHRENIA 2 0.0002
594 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
595 INGUINAL HERNIA 1 0.0002
596 NO THERAPEUTIC RESPONSE 2 0.0002
597 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
598 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
599 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
600 HEPATIC FUNCTION ABNORMAL 6 0.0002
601 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
602 HYPOTENSION 32 0.0002
603 DRUG-INDUCED LIVER INJURY 5 0.0002
604 SWELLING OF EYELID 1 0.0002
605 MULTIPLE INJURIES 1 0.0002
606 NAUSEA 124 0.0002
607 HYPOPHAGIA 4 0.0002
608 METABOLIC ACIDOSIS 5 0.0002
609 ACUTE RESPIRATORY FAILURE 3 0.0002
610 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
611 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
612 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
613 UNRESPONSIVE TO STIMULI 4 0.0002
614 HIATUS HERNIA 2 0.0002
615 ANGINA UNSTABLE 1 0.0002
616 HEPATITIS ACUTE 1 0.0002
617 DEPRESSION 35 0.0002
618 ASPERGILLUS INFECTION 1 0.0002
619 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
620 HAEMATOCRIT DECREASED 3 0.0002
621 UNDERDOSE 11 0.0002
622 TERMINAL STATE 1 0.0001
623 JAUNDICE 4 0.0001
624 THROAT TIGHTNESS 4 0.0001
625 PRODUCT LABEL ISSUE 1 0.0001
626 PYREXIA 51 0.0001
627 TACHYPNOEA 2 0.0001
628 ABNORMAL LOSS OF WEIGHT 1 0.0001
629 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
630 LARGE INTESTINE PERFORATION 1 0.0001
631 AUTOIMMUNE HEPATITIS 1 0.0001
632 CARDIO-RESPIRATORY ARREST 6 0.0001
633 PNEUMONIA 46 0.0001
634 PRODUCT SUPPLY ISSUE 1 0.0001
635 RED BLOOD CELL COUNT DECREASED 4 0.0001
636 GRAFT VERSUS HOST DISEASE 1 0.0001
637 DERMATITIS BULLOUS 1 0.0001
638 INTENTIONAL UNDERDOSE 1 0.0001
639 ACUTE MYOCARDIAL INFARCTION 4 0.0001
640 PSYCHOTIC DISORDER 4 0.0001
641 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
642 RASH MACULO-PAPULAR 3 0.0001
643 HAEMORRHAGE INTRACRANIAL 2 0.0001
644 HYDRONEPHROSIS 1 0.0001
645 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
646 AORTIC ANEURYSM 1 0.0001
647 DEVICE FAILURE 2 0.0001
648 HYPOKALAEMIA 6 0.0001
649 HAEMOLYSIS 1 0.0001
650 ATRIOVENTRICULAR BLOCK 1 0.0001
651 PRODUCT DOSE OMISSION ISSUE 38 0.0001
652 DELUSION 2 0.0001
653 APNOEA 1 0.0001
654 BLOOD ALBUMIN DECREASED 1 0.0001
655 OBESITY 2 0.0001
656 PANCYTOPENIA 7 0.0001
657 OXYGEN SATURATION DECREASED 7 0.0001
658 BLOOD POTASSIUM INCREASED 2 0.0001
659 CONVULSION 7 0.0001
660 LIVER INJURY 3 0.0001
661 POLYURIA 1 0.0001
662 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
663 EMBOLISM 1 0.0001
664 CYTOMEGALOVIRUS INFECTION 2 0.0001
665 PNEUMONIA ASPIRATION 3 0.0001
666 EOSINOPHIL COUNT INCREASED 1 0.0001
667 RHABDOMYOLYSIS 5 0.0001
668 INFUSION SITE ERYTHEMA 1 0.0001
669 ASTHENIA 44 0.0001
670 HAEMATURIA 4 0.0001
671 PYELONEPHRITIS 1 0.0001
672 MYOCARDIAL INFARCTION 20 0.0001
673 URINE OUTPUT DECREASED 1 0.0001
674 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
675 LYMPHOCYTE COUNT DECREASED 2 0.0001
676 CARDIOTOXICITY 1 0.0001
677 HAEMOLYTIC ANAEMIA 1 0.0001
678 MYOSITIS 1 0.0001
679 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
680 GRAND MAL CONVULSION 1 0.0001
681 RENAL DISORDER 5 0.0001
682 THROMBOCYTOPENIA 12 0.0001
683 HAEMOGLOBIN DECREASED 11 0.0001
684 CARDIAC DISORDER 10 0.0001
685 ABORTION INDUCED 1 0.0001
686 DYSPNOEA EXERTIONAL 4 0.0001
687 LEUKAEMIA 1 0.0001
688 PAIN IN JAW 3 0.0001
689 PRODUCT PACKAGING ISSUE 1 0.0001
690 SEROTONIN SYNDROME 2 0.0001
691 LIVER FUNCTION TEST ABNORMAL 3 0.0001
692 DIZZINESS POSTURAL 1 0.0001
693 DYSTONIA 2 0.0001
694 HYPOGLYCAEMIA 5 0.0001
695 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
696 VITAMIN D DEFICIENCY 1 0.0001
697 HEPATOMEGALY 1 0.0001
698 BODY TEMPERATURE DECREASED 1 0.0001
699 DISABILITY 2 0.0001
700 HEART RATE INCREASED 10 0.0001
701 DRUG INEFFECTIVE 133 0.0001
702 HYPOTONIA 1 0.0001
703 BRAIN INJURY 1 0.0001
704 PREMATURE BABY 3 0.0001
705 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
706 BONE MARROW FAILURE 2 0.0001
707 NEUTROPHIL COUNT INCREASED 1 0.0001
708 EUPHORIC MOOD 1 0.0001
709 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
710 EXPOSURE DURING PREGNANCY 6 0.0001
711 SUDDEN DEATH 1 0.0001
712 BRADYCARDIA 5 0.0001
713 HYPOTHYROIDISM 3 0.0001
714 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
715 MENTAL DISORDER 4 0.0001
716 PRODUCT DISPENSING ERROR 2 0.0001
717 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
718 BLOOD PRESSURE INCREASED 14 0.0001
719 ACUTE KIDNEY INJURY 14 0.0001
720 MELAENA 2 0.0001
721 ANAPHYLACTIC REACTION 5 0.0001
722 RASH PAPULAR 2 0.0001
723 THERAPY NON-RESPONDER 4 0.0001
724 STATUS EPILEPTICUS 1 0.0001
725 HEART RATE IRREGULAR 2 0.0001
726 HEADACHE 55 0.0001
727 GASTRIC HAEMORRHAGE 1 0.0001
728 ADVERSE EVENT 8 0.0001
729 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
730 COMA 4 0.0001
731 CHOLECYSTITIS 1 0.0001
732 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
733 BLOOD PRESSURE FLUCTUATION 2 0.0001
734 CEREBROVASCULAR ACCIDENT 14 0.0001
735 C-REACTIVE PROTEIN INCREASED 3 0.0001
736 BURSITIS 1 0.0001
737 CEREBRAL INFARCTION 2 0.0001
738 CYTOPENIA 1 0.0001
739 SMALL INTESTINAL OBSTRUCTION 1 0.0001
740 FLUID RETENTION 4 0.0001
741 INFUSION SITE PAIN 1 0.0001
742 PLATELET COUNT INCREASED 1 0.0001
743 NODULE 1 0.0001
744 GASTRITIS 2 0.0001
745 DISORIENTATION 3 0.0001
746 DRUG INTERACTION 12 0.0001
747 CHEST PAIN 14 0.0001
748 BLOOD BILIRUBIN INCREASED 2 0.0001
749 NEUTROPHIL COUNT DECREASED 3 0.0001
750 TREATMENT NONCOMPLIANCE 4 0.0001
751 CORONARY ARTERY OCCLUSION 1 0.0001
752 PERIPHERAL COLDNESS 1 0.0001
753 RESPIRATORY DISTRESS 2 0.0001
754 MENTAL STATUS CHANGES 2 0.0001
755 MEDICATION ERROR 4 0.0001
756 DEVICE OCCLUSION 1 0.0001
757 SEASONAL ALLERGY 1 0.0001
758 DIALYSIS 1 0.0001
759 SUBDURAL HAEMATOMA 1 0.0001
760 ACCIDENTAL UNDERDOSE 1 0.0001
761 PARAESTHESIA ORAL 1 0.0001
762 HYPOKINESIA 1 0.0001
763 FLUID OVERLOAD 1 0.0001
764 TACHYCARDIA 6 0.0001
765 BLOOD POTASSIUM DECREASED 2 0.0001
766 HYPOAESTHESIA ORAL 1 0.0001
767 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
768 EMOTIONAL DISORDER 2 0.0001
769 ACUTE MYELOID LEUKAEMIA 1 0.0001
770 SWOLLEN TONGUE 2 0.0001
771 BRAIN FOG 1 0.0001
772 ARRHYTHMIA 3 0.0001
773 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
774 HALLUCINATION, AUDITORY 1 0.0001
775 INTERSTITIAL LUNG DISEASE 3 0.0001
776 METASTASES TO BONE 1 0.0001
777 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
778 FEBRILE NEUTROPENIA 4 0.0001
779 BACK PAIN 14 0.0001
780 LEUKOPENIA 3 0.0001
781 PALPITATIONS 7 0.0001
782 PERICARDITIS 1 0.0001
783 MUSCULOSKELETAL DISCOMFORT 1 0.0001
784 ECZEMA 3 0.0001
785 COLD SWEAT 1 0.0001
786 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
787 HEAD DISCOMFORT 1 0.0001
788 ISCHAEMIC STROKE 1 0.0001
789 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
790 OEDEMA 3 0.0001
791 ACCIDENTAL OVERDOSE 2 0.0001
792 AGRANULOCYTOSIS 1 0.0001
793 ABDOMINAL PAIN UPPER 11 0.0001
794 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
795 GASTRIC ULCER 1 0.0001
796 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
797 POST PROCEDURAL COMPLICATION 1 0.0001
798 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
799 BLOOD PRESSURE ABNORMAL 1 0.0001
800 SYNCOPE 5 0.0000
801 FULL BLOOD COUNT DECREASED 1 0.0000
802 FEEDING DISORDER 1 0.0000
803 FATIGUE 38 0.0000
804 RIB FRACTURE 1 0.0000
805 INFECTION 7 0.0000
806 PERITONITIS 1 0.0000
807 HALLUCINATION, VISUAL 1 0.0000
808 RETCHING 1 0.0000
809 HYPOACUSIS 2 0.0000
810 AMNESIA 3 0.0000
811 DEVICE DISLOCATION 2 0.0000
812 DIARRHOEA 29 0.0000
813 HEPATOTOXICITY 1 0.0000
814 THROAT IRRITATION 2 0.0000
815 PRODUCT AVAILABILITY ISSUE 1 0.0000
816 MUSCLE TWITCHING 1 0.0000
817 CHILLS 5 0.0000
818 PRODUCTIVE COUGH 2 0.0000
819 RASH ERYTHEMATOUS 2 0.0000
820 DIABETIC KETOACIDOSIS 1 0.0000
821 PRESYNCOPE 1 0.0000
822 URINARY TRACT INFECTION 7 0.0000
823 ENCEPHALOPATHY 1 0.0000
824 CELLULITIS 2 0.0000
825 GASTRIC CANCER 1 0.0000
826 COUGH 11 0.0000
827 LOSS OF CONSCIOUSNESS 5 0.0000
828 ANAPHYLACTIC SHOCK 1 0.0000
829 HAEMATOMA 1 0.0000
830 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
831 RESPIRATORY TRACT INFECTION 1 0.0000
832 HAEMORRHAGE 4 0.0000
833 SEDATION 1 0.0000
834 PAIN OF SKIN 1 0.0000
835 SKIN LESION 1 0.0000
836 RESPIRATORY ARREST 1 0.0000
837 HYPERSOMNIA 1 0.0000
838 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
839 RESPIRATORY DISORDER 1 0.0000
840 APHASIA 1 0.0000
841 DRUG ADMINISTRATION ERROR 1 0.0000
842 GYNAECOMASTIA 1 0.0000
843 NERVOUS SYSTEM DISORDER 1 0.0000
844 DYSPHAGIA 3 0.0000
845 RHINORRHOEA 2 0.0000
846 NEUTROPENIA 4 0.0000
847 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
848 HEPATIC ENZYME INCREASED 2 0.0000
849 ERYTHEMA 6 0.0000
850 LYMPHADENOPATHY 1 0.0000
851 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
852 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
853 DRUG EFFECT INCOMPLETE 1 0.0000
854 HYPERGLYCAEMIA 1 0.0000
855 PANIC ATTACK 1 0.0000
856 INFLUENZA 3 0.0000
857 DYSARTHRIA 1 0.0000
858 HALLUCINATION 2 0.0000
859 HOT FLUSH 2 0.0000
860 CHRONIC KIDNEY DISEASE 2 0.0000
861 SEIZURE 3 0.0000
862 PERIPHERAL SWELLING 4 0.0000
863 PLASMA CELL MYELOMA 1 0.0000
864 ABNORMAL BEHAVIOUR 1 0.0000
865 TREATMENT FAILURE 2 0.0000
866 POLLAKIURIA 1 0.0000
867 URTICARIA 4 0.0000
868 OVERDOSE 5 0.0000
869 DEVICE LEAKAGE 1 0.0000
870 COVID-19 4 0.0000
871 DEHYDRATION 3 0.0000
872 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
873 WEIGHT INCREASED 5 0.0000
874 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
875 VISION BLURRED 3 0.0000
876 SKIN DISCOLOURATION 1 0.0000
877 NASOPHARYNGITIS 4 0.0000
878 OROPHARYNGEAL PAIN 2 0.0000
879 HYPERSENSITIVITY 4 0.0000
880 DECREASED APPETITE 5 0.0000
881 COGNITIVE DISORDER 1 0.0000
882 PAIN IN EXTREMITY 6 0.0000
883 FLUSHING 2 0.0000
884 CHEST DISCOMFORT 2 0.0000
885 HOSPITALISATION 3 0.0000
886 ILLNESS 2 0.0000
887 INFLAMMATION 1 0.0000
888 PANCREATITIS 1 0.0000
889 RASH PRURITIC 1 0.0000
890 HAEMATOCHEZIA 1 0.0000
891 NECK PAIN 1 0.0000
892 TOXICITY TO VARIOUS AGENTS 3 0.0000
893 INCORRECT DOSE ADMINISTERED 4 0.0000
894 LETHARGY 1 0.0000
895 NASAL CONGESTION 1 0.0000
896 DISEASE PROGRESSION 2 0.0000
897 IRRITABILITY 1 0.0000
898 THERAPEUTIC RESPONSE DECREASED 1 0.0000
899 SUICIDE ATTEMPT 1 0.0000
900 ILL-DEFINED DISORDER 1 0.0000
901 VERTIGO 1 0.0000
902 INJECTION SITE ERYTHEMA 2 0.0000
903 RASH 7 0.0000
904 PRURITUS 6 0.0000
905 INTENTIONAL OVERDOSE 1 0.0000
906 DEEP VEIN THROMBOSIS 1 0.0000
907 DEVICE DIFFICULT TO USE 1 0.0000
908 INFUSION RELATED REACTION 1 0.0000
909 DEVICE MALFUNCTION 1 0.0000
910 DIZZINESS 7 0.0000
911 AGITATION 1 0.0000
912 EPISTAXIS 1 0.0000
913 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
914 FALL 4 0.0000
915 DRUG ABUSE 1 0.0000
916 ABDOMINAL DISCOMFORT 2 0.0000
917 SKIN EXFOLIATION 1 0.0000
918 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
919 MALAISE 5 0.0000
920 INSOMNIA 3 0.0000
921 NO ADVERSE EVENT 2 0.0000
922 MUSCLE SPASMS 2 0.0000
923 WEIGHT DECREASED 3 0.0000
924 BLOOD GLUCOSE INCREASED 2 0.0000
925 GAIT DISTURBANCE 2 0.0000
926 DYSPEPSIA 1 0.0000
927 INJECTION SITE PAIN 3 0.0000
928 FEELING ABNORMAL 2 0.0000
929 HYPERHIDROSIS 1 0.0000
930 DRY SKIN 1 0.0000
931 PRODUCT QUALITY ISSUE 1 0.0000
932 MEMORY IMPAIRMENT 1 0.0000
933 ARTHRALGIA 3 0.0000
934 DRUG DEPENDENCE 1 0.0000
935 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000